{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:18:56Z","timestamp":1786115936476,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09816-9","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:41:05Z","timestamp":1785998465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell-based ELISA using intact HEp-2 cells: an alternative approach for antinuclear antibody detection"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0531-2746","authenticated-orcid":false,"given":"Faruk","family":"Di\u015fli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7872-790X","authenticated-orcid":false,"given":"Sedat","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"2","key":"9816_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1542\/pir.2020-001230","volume":"43","author":"E - Rodriguez-Ballestas","year":"2022","unstructured":"Rodriguez-Ballestas E, Reid-Adam J. Nephrotic syndrome. Pediatr Rev. 2022;43(2):87\u201399.","journal-title":"Pediatr Rev"},{"key":"9816_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-018-8718-8","volume":"58","author":"A - Stochmal","year":"2020","unstructured":"Stochmal A, Czuwara J, Trojanowska M, Rudnicka L. Antinuclear antibodies in systemic sclerosis: an update. Clin Rev Allergy Immunol. 2020;58:40\u201351.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"9816_CR3","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1093\/labmed\/lmy024","volume":"49","author":"LM - Sur","year":"2018","unstructured":"Sur LM, Floca E, Sur DG, Colceriu MC, Samasca G, Sur G. Antinuclear antibodies: marker of diagnosis and evolution in autoimmune diseases. Lab Med. 2018;49(3):e62\u201373.","journal-title":"Lab Med"},{"issue":"3","key":"9816_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1297-319X(03)00019-8","volume":"70","author":"R - Ram\u00edrez-Sandoval","year":"2003","unstructured":"Ram\u00edrez-Sandoval R, S\u00e1nchez-Rodr\u00edguez SH, Herrera-van Oostdam D, Avalos-D\u00edaz E, Herrera-Esparza R. Antinuclear antibodies recognize cellular autoantigens driven by apoptosis. Joint Bone Spine. 2003;70(3):187\u201394.","journal-title":"Joint Bone Spine"},{"key":"9816_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s000110050718","volume":"50","author":"CL - Yu","year":"2001","unstructured":"Yu CL, Sun KH, Tsai CY, Hsieh SC, Yu HS. Anti-dsDNA antibody up-regulates interleukin 6, but not cyclooxygenase, gene expression in glomerular mesangial cells: a marker of immune-mediated renal damage? Inflamm Res. 2001;50:12\u20138.","journal-title":"Inflamm Res"},{"issue":"8","key":"9816_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrrheum.2017.74","volume":"13","author":"DS - Pisetsky","year":"2017","unstructured":"Pisetsky DS. Antinuclear antibody testing\u2014misunderstood or misbegotten? Nat Rev Rheumatol. 2017;13(8):495\u2013502.","journal-title":"Nat Rev Rheumatol"},{"key":"9816_CR7","doi-asserted-by":"publisher","first-page":"100145","DOI":"10.1016\/j.jtauto.2022.100145","volume":"5","author":"LEC - Andrade","year":"2022","unstructured":"Andrade LEC, Damoiseaux J, Vergani D, Fritzler MJ. Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases. J translational Autoimmun. 2022;5:100145.","journal-title":"J translational Autoimmun"},{"issue":"12","key":"9816_CR8","doi-asserted-by":"publisher","first-page":"e00270","DOI":"10.1128\/CVI.00270-17","volume":"24","author":"AE - Tebo","year":"2017","unstructured":"Tebo AE. Recent approaches to optimize laboratory assessment of antinuclear antibodies. Clin Vaccine Immunol. 2017;24(12):e00270\u201317.","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"9816_CR9","first-page":"171","volume":"37","author":"E - Tonutti","year":"2004","unstructured":"Tonutti E, Bassetti D, Piazza A, Visentini D, Poletto M, Bassetto F, Bizzaro N. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation five commercial kits Autoimmun. 2004;37(2):171\u20136.","journal-title":"Evaluation five commercial kits Autoimmun"},{"issue":"9","key":"9816_CR10","first-page":"1612","volume":"40","author":"W - Emlen","year":"1997","unstructured":"Emlen W, O\u2019Neill L. Clinical significance of antinuclear antibodies. Comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. A&R ACR. 1997;40(9):1612\u20138.","journal-title":"A&R ACR"},{"issue":"2","key":"9816_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1128\/cdli.4.2.185-188.1997","volume":"4","author":"RA - Gniewek","year":"1997","unstructured":"Gniewek RA, Stites DP, McHugh TM, Hilton JF, Nakagawa M. Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay. Clin Diagn Lab Immunol. 1997;4(2):185\u20138.","journal-title":"Clin Diagn Lab Immunol"},{"key":"9816_CR12","first-page":"51211","volume":"88","author":"C Buchner","year":"2014","unstructured":"Buchner C, Bryant C, Eslami A, Lakos G. Anti-nuclear antibody screening using HEp-2 cells. J visualized experiments: JoVE. 2014;88:51211.","journal-title":"J visualized experiments: JoVE"},{"key":"9816_CR13","first-page":"51995","volume":"91","author":"M - Veillette","year":"2014","unstructured":"Veillette M, Coutu M, Richard J, Batraville LA, D\u00e9sormeaux A, Roger M, Finzi A. Conformational evaluation of HIV-1 trimeric envelope glycoproteins using a cell-based ELISA assay. J visualized experiments: JoVE. 2014;91:51995.","journal-title":"J visualized experiments: JoVE"},{"issue":"1\u20132","key":"9816_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jim.2009.04.006","volume":"345","author":"D - Jamieson","year":"2009","unstructured":"Jamieson D, Cresti N, Verrill MW, Boddy AV. Development and validation of cell-based ELISA for the quantification of trastuzumab in human plasma. J Immunol Methods. 2009;345(1\u20132):106\u201311.","journal-title":"J Immunol Methods"},{"issue":"1","key":"9816_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/15321819408009571","volume":"15","author":"NM - Monc\u00e9","year":"1994","unstructured":"Monc\u00e9 NM, Cappel VL, Saqueton CB. A comparison of two fixatives on IFA HEp-2 slides for the detection of antinuclear antibodies. J Immunoass Immunochemistry. 1994;15(1):55\u201368.","journal-title":"J Immunoass Immunochemistry"},{"issue":"1","key":"9816_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5858\/2000-124-0071-GFCUOT","volume":"124","author":"A - Kavanaugh","year":"2000","unstructured":"Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med. 2000;124(1):71\u201381.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"9816_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cyto.a.20223","volume":"69","author":"D - Hahm","year":"2006","unstructured":"Hahm D, Anderer U. Establishment of HEp-2 cell preparation for automated analysis of ANA fluorescence pattern. Cytometry Part A: J Int Soc Anal Cytol. 2006;69(3):178\u201381.","journal-title":"Cytometry Part A: J Int Soc Anal Cytol"},{"issue":"6","key":"9816_CR18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/jalm\/jfac050","volume":"7","author":"AM - Velez","year":"2022","unstructured":"Velez AM, Abreu, et al. Patterns of antinuclear antibodies in a new variant of endemic pemphigus in El Bagre, Colombia, colocalizing with antigens against MIZAP, ARVCF, p0071, and desmoplakins I and II. J Appl Lab Med. 2022;7(6):1366\u201378.","journal-title":"J Appl Lab Med"},{"issue":"2","key":"9816_CR19","doi-asserted-by":"publisher","first-page":"021012","DOI":"10.1117\/1.3090448","volume":"14","author":"AL Van de Ven","year":"2009","unstructured":"Van de Ven AL, Adler-Storthz K, Rebecca Richards-Kortum. Delivery of optical contrast agents using Triton-X100, part 1: reversible permeabilization of live cells for intracellular labeling. J Biomed Opt. 2009;14(2):021012\u2013021012.","journal-title":"J Biomed Opt"},{"issue":"5","key":"9816_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/PAI.0b013e318219a6e6","volume":"19","author":"G - Bussolati","year":"2011","unstructured":"Bussolati G, Radulescu RT. Blocking endogenous peroxidases in immunohistochemistry: a mandatory, yet also subtle measure. Appl Immunohistochem Mol Morphology. 2011;19(5):484.","journal-title":"Appl Immunohistochem Mol Morphology"},{"key":"9816_CR21","volume-title":"Glutamate receptors: methods and protocols","year":"2019","unstructured":"Burger C, Velardo MJ, editors. Glutamate receptors: methods and protocols. New York: Springer; 2019."},{"key":"9816_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.mex.2017.03.002","volume":"4","author":"T Waritani","year":"2017","unstructured":"Waritani T, Chang J, McKinney B, Terato K. An ELISA protocol to improve the accuracy and reliability of serological antibody assays. MethodsX. 2017;4:153\u201365.","journal-title":"MethodsX"},{"issue":"2","key":"9816_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.37990\/medr.1134367","volume":"5","author":"Y - Y\u0131lmaz","year":"2023","unstructured":"Y\u0131lmaz Y, Di\u015fli F, Kaplan F, Y\u0131ld\u0131z S. BSA Interference in Immunoassays in Individuals with Egg Allergy. Med Records. 2023;5(2):187\u201391.","journal-title":"Med Records"},{"issue":"1\u20132","key":"9816_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0022-1759(01)00419-7","volume":"255","author":"JA - Nemzek","year":"2001","unstructured":"Nemzek JA, Siddiqui J, Remick DG. Development and optimization of cytokine ELISAs using commercial antibody pairs. J Immunol Methods. 2001;255(1\u20132):149\u201357.","journal-title":"J Immunol Methods"},{"key":"9816_CR25","doi-asserted-by":"crossref","unstructured":"Bradwell AR, Hughes RG, Karim AR. Immunofluorescent antinuclear antibody tests. Man Mol Clin Lab Immunol. 2006. pp. 995\u20131006.","DOI":"10.1128\/9781555815905.ch112"},{"issue":"5","key":"9816_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1128\/CDLI.10.5.934-939.2003","volume":"10","author":"C - Drouet","year":"2003","unstructured":"Drouet C, Nissou MF, Ponard D, Arvieux J, Dumestre-P\u00e9rard C, Gaudin P, Sarrot-Reynauld F. Detection of antiendothelial cell antibodies by an enzyme-linked immunosorbent assay using antigens from cell lysate: minimal interference with antinuclear antibodies and rheumatoid factors. Clin Vaccine Immunol. 2003;10(5):934\u20139.","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"9816_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1309\/AJCP6R8EELGODAYW","volume":"135","author":"SS - Copple","year":"2011","unstructured":"Copple SS, Sawitzke AD, Wilson AM, Tebo AE, Hill HR. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis. Am J Clin Pathol. 2011;135(5):678\u201384.","journal-title":"Am J Clin Pathol"},{"key":"9816_CR28","volume-title":"Bioanalytical method validation \u2014 guidance for industry (May 22, 2018)","author":"US, Center for Veterinary Medicine","year":"2018","unstructured":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Bioanalytical Method Validation: Guidance for Industry. Silver Spring (MD): U.S. Food and Drug Administration; 2018. p. 20\u201327. Available from: https:\/\/www.fda.gov\/media\/70858\/download"},{"issue":"8","key":"9816_CR29","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/annrheumdis-2022-222168","volume":"81","author":"MY - Choi","year":"2022","unstructured":"Choi MY, Clarke AE, Urowitz M, Hanly J, St-Pierre Y, Gordon C, Fritzler MJ. Longitudinal analysis of ANA in the systemic lupus international collaborating clinics (SLICC) inception cohort. Ann Rheum Dis. 2022;81(8):1143\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"9816_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/1745-7580.1000155","volume":"14","author":"D Karumanchi","year":"2018","unstructured":"Karumanchi D, Oommen S. Evaluation of diagnostic significance and cost effectiveness of Elisa and IFA for the diagnosis of autoimmune disorders. Immunome Res. 2018;14(2):1\u20136.","journal-title":"Immunome Res"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09816-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:41:07Z","timestamp":1785998467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09816-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9816"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09816-9","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Scientific Research and Publication Ethics Committee of Bing\u00f6l University Health Sciences prior to the study (Approval No: 04\/10).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"79"}}